Mycofenolaat Mofetil Mylan (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mycofenolaat Mofetil Mylan, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat lupus nephritis in appropriate patient populations.

GNH USA supplies Mycofenolaat Mofetil Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is used in the management of immune‑mediated conditions, particularly in solid‑organ transplantation and autoimmune kidney disease. - Kidney transplant rejection: helps prevent acute and chronic rejection of the transplanted kidney. - Heart transplant rejection: reduces the risk of immune‑mediated damage to the transplanted heart. - Lupus nephritis: diminishes renal inflammation and proteinuria in patients with systemic lupus erythematosus.

Mycophenolate Mofetil may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Headache: occasional tension‑type headache. - Tremor: fine shaking of hands. - Increased susceptibility to infections: higher frequency of mild infections.

Serious or Rare Side Effects: - Severe infection: opportunistic or life‑threatening infections. - Bone marrow suppression: leukopenia, anemia, or thrombocytopenia. - Liver toxicity: elevated transaminases or hepatitis. - Progressive multifocal leukoencephalopathy (PML): rare viral brain infection. - Malignancy risk: increased incidence of certain cancers. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before initiating therapy, several safety considerations should be observed. - Monitor blood counts: regular CBC to detect leukopenia or anemia. - Monitor liver function: periodic LFTs to identify hepatotoxicity. - Avoid live vaccines: live attenuated vaccines may cause infection. - Use effective contraception: teratogenic potential requires pregnancy prevention. - Adjust dose in renal impairment: renal function may necessitate dose modification. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mycophenolate Mofetil can interact with several medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increased mycophenolic acid exposure. - Tacrolimus: heightened immunosuppressive effect. - Live vaccines: risk of vaccine‑derived infection. - Strong CYP3A4 inducers (e.g., rifampin): reduced drug levels.

Moderate Interactions (Monitor Closely): - Antacids (aluminum or magnesium): may decrease absorption. - NSAIDs: potential for increased nephrotoxicity. - Non‑live vaccines: monitor immune response efficacy.